title: Angiotensin converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) and lactation: an update.
abstract: Angiotensin converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) are commonly used for the treatment of hypertension. ACEIs have been promoted as first-line therapy for selected patients with chronic hypertension and for the prevention of diabetic nephropathy, thus creating the potential for frequent ACEI exposure among women of childbearing age. ARBs are the most recent addition to the available options for antihypertensive agents. This review specifically focuses on the most up-to-date information regarding these newer antihypertensives with regard to lactation.
authors.affiliation: Searle Pharmaceuticals in Skokie, Illinois, USA.
authors.forename: M E
authors.initials: ME
authors.lastname: Shannon
authors.forename: S E
authors.initials: SE
authors.lastname: Malecha
authors.forename: A J
authors.initials: AJ
authors.lastname: Cha
mesh_terms: D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000493:pharmacokinetics*; D000959:Antihypertensive Agents / Q000493:pharmacokinetics*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008895:Milk, Human / Q000737:chemistry*
chemical_list: D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents